1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Lymphoma, Follicular, Marginal Zone: new trials by email Literature Review of Lymphoma, Follicular, Marginal Zone trials Research Report on Lymphoma, Follicular, Marginal Zone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of TAK-659 as a Single Agent in Adult East Asian Participants With Non-Hodgkin Lymphoma (NHL) TAK-659 - Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Marginal Zone | Phase 1 | Terminated | Calithera Biosciences, Inc | 17 | 2017-08-01 | 2023-02-08 |
Lymphoma (1) · Lymphoma, Non-Hodgkin (1)
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
TAK-659 (1)
Calithera Biosciences, Inc (1)
Japan (1) · South Korea (1)